A new drug is on the market fighting HIV at its genetic root.
Merck & Co. is developing a new drug called Isnetress, which attacks integrase, an enzyme produced by the HIV and AIDS viruses which enable it to integrate with a cells DNA and essentially corrupt it with virus. This new drug would essentially take an aggressive approach, attacking the HIV virus, as opposed to previous treatments which have been designed to build up the body's immune system and create defenses from HIV/AIDS.
Merck will recieve a decision from the FDA which could allow the drug to be used on adult patients who are resistent to other forms of treatment. More research is needed before it can begin to be used on children.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment